Nuwellis, Inc. NUWE
Set alert
5.38 USD -0.30 -5.26%
As of Nov 2, 1:58 PM ET
5.21 Day range 5.65
2.52 52-week range 1,556.10
- YTD
- -91.16%
- 1 year
- -94.62%
- Open
- 5.65
- Prev close
- 5.68
- Mkt cap
- 2.18M
- Vol
- 52.76K
- Avg vol
- 891.78K
- EPS
- 3,923.28
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 5.21
- High
- 5.65
- Forward P/E
- -0.41
- Beta
- 0.36
- Short ratio
- 0.26
- Inst. own
- 1.46%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 1.53
- 200-d avg
- 5.15
- 1y target
- 16.00
1Y chart
Events in this range
- Jun 26, 2026Split: 1 for 35
- Oct 27, 2026Split: 1 for 9
Signals (32)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 27, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 27, 2026 | 6 days ago |
| RSI: Overbought | Oct 27, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 23, 2026 | 1 week ago |
| RSI: Oversold | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Oct 14, 2026 | 2 weeks ago |
| RSI: Oversold | Aug 31, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 23, 2026 | 4 months ago |
| RSI: Oversold | May 29, 2026 | 5 months ago |
| RSI: Oversold | May 27, 2026 | 5 months ago |
| MACD: Sell Signal | May 26, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| MACD: Sell Signal | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | Mar 23, 2026 | 7 months ago |
| RSI: Oversold | Mar 17, 2026 | 7 months ago |
| SMA: Bearish | Feb 11, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 6, 2026 | 8 months ago |
| RSI: Overbought | Feb 3, 2026 | 9 months ago |
| SMA: Bullish | Jan 27, 2026 | 9 months ago |
| RSI: Overbought | Jan 27, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Jan 23, 2026 | 9 months ago |
| SMA: Bearish | Jan 16, 2026 | 9 months ago |
| SMA: Bullish | Jan 15, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 6, 2026 | 10 months ago |
| MACD: Sell Signal | Dec 18, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 17, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 14, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 13, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 7, 2025 | 12 months ago |
| MACD: Sell Signal | Nov 5, 2025 | 12 months ago |
Key statistics
- Market cap
- 4.64M
- Enterprise value
- 2.30M
- Trailing P/E
- 0.00
- Forward P/E
- -0.41
- PEG ratio
- 0.00
- Price / sales
- 0.51
- Price / book
- 0.06
- EPS (TTM)
- -60.77
- Beta
- 0.36
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -232.24%
- Revenue (TTM)
- 9.01M
- Revenue growth
- 5.70%
- Free cash flow
- -12.32M
- Total cash
- 1.02M
- Total debt
- 654.00K
- Return on equity
- -987.45%
- Shares outstanding
- 4.37M
- Short % of float
- 17.27%
- 50-day average
- 1.53
- 200-day average
- 5.15
Analyst view
Consensus: none
Price target (mean) 16.00
Ratings (0m) 2 1 buy · 1 hold · 0 sell
- Strong buy1
- Buy0
- Hold1
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
NUWE Revenue — quarterly 1.97M
NUWE Net income — quarterly -4.83M
NUWE EPS — quarterly -240.00
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -0.88 | 1.74 | +2.62 | +297.73% |
| Aug 13, 2024 | Jun 1, 2024 | -9.49 | -18.85 | -9.36 | -98.63% |
| May 7, 2024 | Mar 1, 2024 | 0.00 | -20.98 | — | — |
| Mar 5, 2024 | Dec 1, 2023 | 0.00 | -78.32 | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.00 | -63.29 | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.00 | -127.62 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 13, 2024 | Roth MKM | reit | Buy | Buy |
| Jul 29, 2024 | Roth MKM | init | — | Buy |
| Nov 8, 2023 | Ladenburg Thalmann | down | Buy | Neutral |
About Nuwellis, Inc.
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- nuwellis.com
News
- Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology
- Nuwellis, Inc. (NASDAQ:NUWE) Shares Shorted: Short Interest Up 339.6% in September
- Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
- Nuwellis To Participate In Four Medical Conference This Month To Present Data, Discuss Role Of Its Aquadex SmartFlow System
- Nuwellis to Highlight Advancements in Fluid Management Across Pediatric Care, Critical Care, and Heart Failure at Leading October Medical Conferences
- Nuwellis, Inc. (NASDAQ:NUWE) Sees Significant Decline in Short Interest
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity
Your note
Sign in to keep a note on NUWE — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| JARAMILLO NESTOR JR, | Chief Executive Officer | Purchase | Mar 14, 2023 | 4,098 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| HRT Financial LP | 0.35% | 15,127 | 16.03K | Sep 29, 2024 |
| Two Sigma Securities, LLC | 0.31% | 13,631 | 14.45K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.15% | 6,346 | 6.73K | Sep 29, 2024 |
| Morgan Stanley | 0.01% | 312 | 330 | Sep 29, 2024 |
| JP Morgan Chase & Company | 0.00% | 1 | 1 | Sep 29, 2024 |
| Bank of America Corporation | 0.00% | 11 | 11 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.17% | 7,478 | 7.93K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 3,189 | 3.38K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 2,759 | 2.92K | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.03% | 1,426 | 1.51K | Sep 29, 2024 |